Cellnovo Group (“Cellnovo” CLNV: EN Paris), a medical technology company marketing the first mobile, connected, all-in-one diabetes management system, today announces that Javaid Masoud has been appointed as Chief Technology Officer effective immediately. Mr. Masoud has a proven track record of bringing new medical technologies from concept to product release with a system perspective. Working in the US and Europe, he is recognized for his consistent results and effective leadership in technology and product development by leading multi-functional international teams. Mr. Masoud was previously Senior Director of Patient Management System R&D at Sorin Group, a leading global medical technology company, where he led the international hardware and software product development teams. Previously, Mr. Masoud worked at Medtronic USA, Minnesota, where he served as a Technical Fellow, a highly honored position responsible for setting the new technical direction for the Company as a technical educator, mentor and consultant. At Medtronic he directed teams for wireless technologies, embedded firmware development for implantable cardiac defibrillators and external instruments from a systems perspective.